Several prospective studies have investigated immunological biomarkers for NHL, including interleukin (IL)-6, IL-10, tumor necrosis factor (TNF)-α, CXCL13, soluble CD23 (sCD23), sCD27, and sCD30 [32,33]. The gene discussed is TNF; the disease is non-Hodgkin lymphoma.